Women with polycystic ovary syndrome exhibit impaired endometrial receptivity with excessive ERα and histone lactylation

Hongying Shan, Yue Wang, Baoying Liao, Kai-Lun Hu, X H Chen, Chenxi Xiao, Zi Yang, Fenting Liu, Tianliu Peng, Mingmei Lin, Feng Deng, Ping Zhou, Yang Yu, Rong Li, Heng PanNature Communications 2026 · DOI

TL;DR

This study reveals that women with Polycystic Ovary Syndrome (PCOS) experience impaired endometrial receptivity, leading to reduced fertility, due to excessive estrogen receptor alpha (ERα) and histone lactylation. Targeting these molecular pathways, particularly by inhibiting lactate production, shows promise for improving fertility in PCOS patients.

What Problem Does This Paper Address?

Polycystic Ovary Syndrome (PCOS) is a leading cause of infertility in women, often attributed solely to ovulatory dysfunction. However, accumulating evidence suggests that endometrial dysfunction also plays a significant role, independent of ovarian issues. The exact mechanisms behind this endometrial dysfunction in PCOS have remained unclear, with previous studies often confounded by factors like embryo quality and comorbidities. This paper aims to dissect the specific contribution of the endometrium to PCOS infertility and elucidate the underlying molecular mechanisms.

Methods

The researchers employed a multi-pronged approach:

  • Retrospective Cohort Study: They analyzed data from a large cohort (n=4278) of women undergoing frozen-thawed embryo transfer (FET) cycles. By strictly controlling for embryonic factors and using propensity score matching (PSM), they isolated the impact of PCOS on implantation rates and other pregnancy outcomes.
  • Human Endometrial Samples: Biopsies from women with and without PCOS were used to assess molecular markers of endometrial function, including proliferation, decidualization, and the expression of key receptors and genes.
  • In Vitro Studies: Ishikawa cells, a human endometrial adenocarcinoma cell line, were manipulated to overexpress estrogen receptor alpha (ESR1-OE) to investigate the role of ERα in regulating histone lactylation and lactate production.
  • PCOS Mouse Model: A dehydroepiandrosterone (DHEA)-induced PCOS mouse model was used to validate findings from human studies and to test therapeutic interventions. This model allowed for the examination of uterine receptivity, ERα and histone lactylation levels, and the impact of pharmacological interventions.
  • Molecular Techniques: A range of techniques were utilized, including immunohistochemistry (IHC), immunofluorescence (IF), Western blotting, quantitative real-time PCR (qRT-PCR), CUT&Tag for epigenetic analysis, and lactate assays.

Datasets

The primary dataset used was a retrospective cohort of 4278 women undergoing IVF/ICSI treatments at Peking University Third Hospital between January 2018 and December 2021. This cohort was divided into PCOS (n=1649) and control (n=2629) groups. Propensity score matching was applied to create comparable groups for analysis. Additional datasets included human endometrial tissue samples and data from the DHEA-induced PCOS mouse model.

Key Insights and Ideas

  • Endometrial Dysfunction is a Key Player in PCOS Infertility: The study provides strong evidence that impaired endometrial receptivity, independent of oocyte or embryo quality, significantly contributes to the lower implantation rates observed in women with PCOS.
  • ERα and Histone Lactylation are Interconnected and Dysregulated in PCOS: The research highlights a crucial interplay between excessive estrogen receptor alpha (ERα) and increased histone lactylation (specifically H3K18la) in the endometrium of women with PCOS. This dysregulation appears to be a core mechanism driving the infertility.
  • Lactate Production Fuels the Problem: Elevated intracellular lactate levels in PCOS endometria are linked to increased histone lactylation. This suggests that metabolic changes within the endometrium are directly influencing its function.
  • A Vicious Cycle: The study proposes a feedback loop where ERα overexpression promotes lactate production and histone lactylation, which in turn further enhances ERα expression, creating a detrimental cycle for endometrial receptivity.
  • Therapeutic Potential: Targeting either ERα or the lactate production pathway (and thus histone lactylation) showed promise in restoring uterine receptivity and improving implantation rates in the PCOS mouse model, offering a potential new avenue for treating PCOS-related infertility.

Key Results

  • Clinical Outcomes: After PSM, women with PCOS showed significantly lower implantation rates (45.7% vs. 49.9%), positive pregnancy rates (54.7% vs. 58.8%), and live birth rates (32.9% vs. 39.2%) compared to controls.
  • Endometrial Markers: PCOS endometria exhibited excessive epithelial proliferation, impaired stromal decidualization, and downregulation of key decidual markers (IGFBP1, PRL).
  • Molecular Dysregulation: Upregulation of ERα and histone lactylation (H3K18la, H4K12la) was observed in PCOS endometria. Estrogen-responsive genes were abnormally elevated, while progesterone-responsive genes showed no significant difference.
  • In Vitro Validation: Overexpression of ESR1 in Ishikawa cells led to increased intracellular lactate, LDHA/LDHB expression, and H3K18la levels.
  • Mouse Model: DHEA-treated PCOS mice displayed impaired uterine receptivity, elevated uterine ERα and H3K18la, and significantly reduced implantation sites.
  • Therapeutic Efficacy: Treatment with an ERα inhibitor (MPP) or a glycolysis inhibitor (oxamate) in PCOS mice restored uterine receptivity and improved implantation rates, with reduced ERα and H3K18la levels.

Limitations and Future Work

  • Mouse Model Limitations: While the DHEA-induced PCOS mouse model recapitulated many aspects of human PCOS, it's acknowledged that the physiology isn't identical, and further validation in other models might be beneficial.
  • Confounding Factors: Although PSM was used to control for confounders, the authors acknowledge the complexity of PCOS and the potential for residual confounding.
  • Metformin's Role: The paper briefly touches upon metformin's potential to rescue endometrial function in PCOS, suggesting a complex interplay with ERα and Kla that warrants further investigation.
  • Gut Microbiota Influence: The discussion mentions the potential influence of gut microbiota and its metabolites on endometrial lactate levels, hinting at a broader systemic connection that could be explored.
  • Therapeutic Optimization: Future work will likely focus on translating these findings into clinical applications, optimizing therapeutic strategies targeting ERα and histone lactylation for PCOS infertility. Understanding the precise balance of ERα and Kla for optimal endometrial receptivity is also a key future direction.

Summary updated

Abstract

Polycystic ovary syndrome (PCOS) is one of the most common reproductive disorders in women and severely impairs fertility. Extant clinical studies can only provide indirect and plausible evidence to support endometrial dysfunction as an ovary-independent contributor to PCOS infertility, considering heterogeneous confounders in their phenotypes, comorbidities, and severities. By strictly controlling embryonic factors and potential confounders, our retrospective cohort study reports an adverse implantation rate in women with PCOS, confirming abnormalities in the endometrium, which are accompanied by excessive ERα and histone lactylation. Next, we validate the cooccurrence of impaired uterine receptivity with elevated ERα and histone lactylation in the PCOS mouse model. Inhibiting histone lactylation could downregulate ERα and estrogen-responsive genes, restore uterine receptivity, and improve the implantation rate in PCOS mice. Here, we show that upregulated ERα and histone lactylation are key indicators of impaired endometrial receptivity in PCOS, providing a potential therapeutic strategy by inhibiting lactate production.
BibTeX
@inproceedings{shan2026women,
  author = {Hongying Shan and Yue Wang and Baoying Liao and Kai-Lun Hu and X H Chen and Chenxi Xiao and Zi Yang and Fenting Liu and Tianliu Peng and Mingmei Lin and Feng Deng and Ping Zhou and Yang Yu and Rong Li and Heng Pan},
  title = {{Women with polycystic ovary syndrome exhibit impaired endometrial receptivity with excessive ERα and histone lactylation}},
  booktitle = {Nature Communications},
  year = {2026},
  doi = {10.1038/s41467-026-68441-0},
}
Figure